TITLE

Aspirin plus dipyridamole was more effective than aspirin alone for preventing vascular events after minor cerebral ischemia

PUB. DATE
November 2006
SOURCE
ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study that was conducted to determine the efficacy of aspirin plus dipyridamole in preventing hypertension and other vascular events after minor cerebral ischemia. About 2763 patients with minor ischemic stroke were included in the study. The study concluded that aspirin plus dipyridamole was more effective than aspirin alone for preventing vascular events.
ACCESSION #
23245674

 

Related Articles

  • A Randomized Trial of E5510 versus Aspirin in Patients with Transient Ischemic Attacks. Maruyama, Shoichi; Uchiyama, Shinichiro; Tohgi, Hideo; Hirai, Shunsaku; Ikeda, Yasuo; Shinohara, Yukito; Matsuda, Tamotsu; Fujishima, Masatoshi; Kameyama, Masakuni // Angiology;Nov1995, Vol. 46 Issue 11, p999 

    In a randomized double-blind trial, the Study Group compared the efficacy of E5510, a novel antiplatelet agent, and aspirin in preventing the recurrence of transient ischemic attacks (TIA). In total, 227 patients who suffered from TIA in the twelve weeks prior to the study were enrolled. They...

  • Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke. McCabe, D. J. H.; Rakhit, R. D. // Journal of Neurology, Neurosurgery & Psychiatry;Jan2007, Vol. 78 Issue 1, p14 

    Peer-reviewed data pertaining to anti-thrombotic and interventional therapy for transient ischaemic attack (TIA) or ischaemic stroke patients with non-valvular atrial fibrillation, atrial flutter, interatrial septal abnormalities, or left ventricular thrombus were reviewed. Long-term oral...

  • NICE stroke evidence queried. Pownall, Mark // GP: General Practitioner;10/21/2005, p9 

    This article reports that the National Institute for Clinical Excellence (NICE)'s recommendations that modified release (MR) dipyridamole should be used in combination with low-dose aspirin for the secondary prevention of stroke or transient ischemic attack have been called into question....

  • What is the best management for patients who have a TIA while on aspirin therapy? Ahmed, Nabila; Coffey, John B. // Journal of Family Practice;Jul2006, Vol. 55 Issue 7, p627 

    The article provides information regarding the best management for patients who experienced transient ischemic attacks (TIA) while on aspirin therapy. An alternative antiplatelet therapy for prevention of stroke is indicated for patients who have TIA while on aspirin therapy. The combination of...

  • Transient ischaemic attack.  // Nursing Standard;12/13/2006, Vol. 21 Issue 14-16, p58 

    A quiz concerning the transient ischaemic attack is presented.

  • 2007 - Review: Risk for stroke is high at 2, 30, and 90 days after transient ischemic attack. Tong, David // ACP Journal Club;6/20/2008, Vol. 148 Issue 4, p11 

    The article discusses the early risk for stroke at 2, 30, and 90 days in patients who have had a transient ischemic attack (TIA). For the research cohort studies reporting the outcome of early risk were selected. It is concluded that risk for strokeat 2, 30, and 90 days after transient ischemic...

  • Adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p68 

    The article addresses the question whether in high-risk patients who have had a transient ischemic attack (TIA) or recent ischemic stroke, aspirin plus clopidogrel is more effective than clopidogrel alone for reducing recurrent ischemic. vascular events. The article concludes that In high-risk...

  • Clopidogrel consistently outshines aspirin in Europe.  // PharmacoEconomics & Outcomes News;6/18/2005, Issue 480, p7 

    Discusses research being done on the cost effectiveness of clopidogrel in treating European patients with a history of ischaemic stroke or transient ischaemic attack compared with aspirin presented at the 10th International Meeting of the International Society for Pharmacoeconomics and Outcomes...

  • COMMENTARY: Adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients. Hankey, Graeme J. // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p68 

    The article presents a commentary on the study, which concluded that adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients. The results of the MATCH trial are consistent with the known effects of aspirin in patients with TIA or...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics